Is erectile dysfunction a marker for cardiovascular disease?

Citation
M. Kirby et al., Is erectile dysfunction a marker for cardiovascular disease?, INT J CL PR, 55(9), 2001, pp. 614-618
Citations number
35
Categorie Soggetti
General & Internal Medicine
Journal title
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
ISSN journal
13685031 → ACNP
Volume
55
Issue
9
Year of publication
2001
Pages
614 - 618
Database
ISI
SICI code
1368-5031(200111)55:9<614:IEDAMF>2.0.ZU;2-1
Abstract
There is now significant evidence that erectile dysfunction (ED) can be a s ymptom of cardiovascular disease, and can act as a marker for disease progr ession. National Health Service (NHS) prescribing restrictions on treatment s for ED have recently been reviewed by the Department of Health, and curre nt arrangements will not change. Unrestricted availability of licensed trea tments for ED on the NHS, irrespective of the cause of the ED, may encourag e men to present for investigation, enabling early detection of cardiovascu lar disease. Sildenafil citrate (Viagra), an effective treatment for ED, ca n also have a direct beneficial effect on cardiovascular disease. Unrestric ted NHS availability of ED treatments such as sildenafil could facilitate g reater achievement of National Service Framework targets for coronary heart disease.